StonvexLoading…
StonvexStonvexStonvexCore line items from PTRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $2.50B | $1.80B | $1.37B |
Operating Income | $25.41M | $87.18M | $52.78M |
Net Income | $16.25M | $67.86M | $41.26M |
EPS (Diluted) | $-1.36 | $0.47 | $0.22 |
Total Assets | $947.64M | $664.42M | Not available |
Total Liabilities | $366.64M | $285.10M | Not available |
Cash & Equivalents | $289.05M | $175.62M | $127.23M |
Free Cash Flow OCF − CapEx | $78.92M | $49.90M | $26.98M |
Shares Outstanding | 115.00M | 90.77M | 90.77M |